ASX - By Stock
|
ACW |
Re:
Ann: First patient treated in ACW XanaMIA ph 2b Alzheimers trial
|
|
thymus
|
26 |
8.3K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
26
|
8.3K
|
2
|
|
ASX - By Stock
|
SMN |
Re:
FAA demands more meaningful changes
|
|
thymus
|
20 |
4.9K |
3 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
20
|
4.9K
|
3
|
|
ASX - By Stock
|
SMN |
Re:
FAA demands more meaningful changes
|
|
thymus
|
20 |
4.9K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
20
|
4.9K
|
1
|
|
Charts
|
ACW |
Re:
ACW Chart Thread
|
|
thymus
|
24 |
8.6K |
3 |
02/03/24 |
02/03/24 |
Charts
|
24
|
8.6K
|
3
|
|
Charts
|
SMN |
Re:
SMN - Chart
|
|
thymus
|
3.2K |
1.2M |
8 |
27/02/24 |
27/02/24 |
Charts
|
3.2K
|
1.2M
|
8
|
|
Charts
|
SMN |
Re:
SMN - Chart
|
|
thymus
|
3.2K |
1.2M |
7 |
26/02/24 |
26/02/24 |
Charts
|
3.2K
|
1.2M
|
7
|
|
Charts
|
SMN |
Re:
SMN - Chart
|
|
thymus
|
3.2K |
1.2M |
6 |
25/02/24 |
25/02/24 |
Charts
|
3.2K
|
1.2M
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Application for quotation of securities - ACW
|
|
thymus
|
25 |
6.6K |
3 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
25
|
6.6K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen awarded UK Innovation Passport for Xanamem
|
|
thymus
|
73 |
17K |
4 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
73
|
17K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen awarded UK Innovation Passport for Xanamem
|
|
thymus
|
73 |
17K |
6 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
73
|
17K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
3.75c ACW optIons
|
|
thymus
|
3 |
1.1K |
8 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
3
|
1.1K
|
8
|
|
Charts
|
SMN |
Re:
SMN - Chart
|
|
thymus
|
3.2K |
1.2M |
5 |
20/01/24 |
20/01/24 |
Charts
|
3.2K
|
1.2M
|
5
|
|
ASX - By Stock
|
SMN |
Re:
Max 9 grounded
|
|
thymus
|
25 |
6.1K |
2 |
07/01/24 |
07/01/24 |
ASX - By Stock
|
25
|
6.1K
|
2
|
|
ASX - By Stock
|
SMN |
Re:
Ann: An update from the Executive Chairman
|
|
thymus
|
191 |
46K |
12 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
191
|
46K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
thymus
|
508 |
121K |
9 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
508
|
121K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
thymus
|
508 |
121K |
3 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
508
|
121K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
thymus
|
508 |
121K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
121K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
thymus
|
508 |
121K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
121K
|
1
|
|
ASX - By Stock
|
SMN |
Re:
Ann: An update from the Executive Chairman
|
|
thymus
|
73 |
19K |
16 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
73
|
19K
|
16
|
|
ASX - By Stock
|
SMN |
Re:
SMN technical analysis chart
|
|
thymus
|
927 |
258K |
13 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
927
|
258K
|
13
|
|
Charts
|
SMN |
Re:
SMN - Chart
|
|
thymus
|
3.2K |
1.2M |
2 |
01/10/23 |
01/10/23 |
Charts
|
3.2K
|
1.2M
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Notification regarding unquoted securities - ACW
|
|
thymus
|
4 |
843 |
0 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
4
|
843
|
0
|
|
ASX - By Stock
|
SMN |
Re:
Ann: Preliminary Final Report
|
|
thymus
|
117 |
31K |
2 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
117
|
31K
|
2
|
|
Charts
|
SMN |
Re:
SMN - Chart
|
|
thymus
|
3.2K |
1.2M |
3 |
15/09/23 |
15/09/23 |
Charts
|
3.2K
|
1.2M
|
3
|
|
Charts
|
SMN |
Re:
SMN - Chart
|
|
thymus
|
3.2K |
1.2M |
4 |
07/09/23 |
07/09/23 |
Charts
|
3.2K
|
1.2M
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen FY2023 results, following the science
|
|
thymus
|
11 |
3.9K |
2 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
11
|
3.9K
|
2
|
|
ASX - By Stock
|
ACW |
Green light
|
|
thymus
|
8 |
2.5K |
6 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
8
|
2.5K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW secures shortfall commitments of $4.56m for rights issue
|
|
thymus
|
18 |
6.3K |
7 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
18
|
6.3K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
thymus
|
450 |
146K |
3 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
146K
|
3
|
|
ASX - By Stock
|
SMN |
Re:
Are we there yet?
|
|
thymus
|
22 |
7.8K |
16 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
22
|
7.8K
|
16
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW secures shortfall commitments of $4.56m for rights issue
|
|
thymus
|
18 |
6.3K |
4 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
18
|
6.3K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW CEO presents at Bioshares Biotech Summit
|
|
thymus
|
9 |
2.8K |
3 |
30/07/23 |
30/07/23 |
ASX - By Stock
|
9
|
2.8K
|
3
|
|
ASX - By Stock
|
SMN |
Re:
Ann: An update from the Executive Chairman
|
|
thymus
|
60 |
18K |
2 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
60
|
18K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
ACW general discussion
|
|
thymus
|
160 |
73K |
0 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
160
|
73K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
ACW general discussion
|
|
thymus
|
160 |
73K |
3 |
01/07/23 |
01/07/23 |
ASX - By Stock
|
160
|
73K
|
3
|
|
ASX - By Stock
|
SMN |
Re:
Military
|
|
thymus
|
33 |
10K |
5 |
25/06/23 |
25/06/23 |
ASX - By Stock
|
33
|
10K
|
5
|
|
ASX - By Stock
|
SMN |
Re:
Military
|
|
thymus
|
33 |
10K |
5 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
33
|
10K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW CEO presentation on emerging oral Alzheimers therapies
|
|
thymus
|
8 |
3.9K |
1 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
8
|
3.9K
|
1
|
|
Charts
|
SMN |
Re:
SMN - Chart
|
|
thymus
|
3.2K |
1.2M |
3 |
12/06/23 |
12/06/23 |
Charts
|
3.2K
|
1.2M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
thymus
|
10K |
3.7M |
9 |
07/06/23 |
07/06/23 |
General
|
10K
|
3.7M
|
9
|
|
ASX - By Stock
|
SMN |
Re:
Show me a sign
|
|
thymus
|
58 |
19K |
13 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
58
|
19K
|
13
|
|
ASX - By Stock
|
SMN |
Re:
Show me a sign
|
|
thymus
|
58 |
19K |
1 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
58
|
19K
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
thymus
|
10K |
3.7M |
5 |
23/05/23 |
23/05/23 |
General
|
10K
|
3.7M
|
5
|
|
ASX - By Stock
|
ACW |
Re:
ACW general discussion
|
|
thymus
|
160 |
73K |
0 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
160
|
73K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
RAC Investor Hub Q&A
|
|
thymus
|
106 |
30K |
6 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
106
|
30K
|
6
|
|
ASX - By Stock
|
SMN |
Re:
Ann: An update from the Executive Chairman
|
|
thymus
|
100 |
33K |
5 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
100
|
33K
|
5
|
|
ASX - By Stock
|
RAC |
Sounds familiar ?
|
|
thymus
|
15 |
5.5K |
44 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
15
|
5.5K
|
44
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
thymus
|
10K |
3.7M |
1 |
03/05/23 |
03/05/23 |
General
|
10K
|
3.7M
|
1
|
|
ASX - By Stock
|
SMN |
Re:
SMN technical analysis chart
|
|
thymus
|
927 |
258K |
0 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
927
|
258K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
thymus
|
133 |
38K |
7 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
133
|
38K
|
7
|
|